Although plasma HA, CD44 and RHAMM expressions were elevated in kidney tissue biopsies, further investigation is needed to ascertain whether these potential biomarkers can be utilized for early intervention in DKD. This evidence concerns the gene CD44 and diabetic kidney disease.